Nelipak is the first healthcare packaging manufacturer to use Eastar Renew 6763 to produce sterile barrier packaging for Class II & III medical device applications.
According to Eastman, Eastar Renew 6763, powered by Eastman’s molecular recycling technologies, is indistinguishable from Eastar 6763 copolyester, with the same durability, safety and performance relied on by medical device companies for decades. The only difference is that by sourcing Eastar Renew, companies can certify that plastic waste is being diverted from landfills to produce new packaging. Currently, the goal is to divert waste volume equal to 25% of the weight of total packaging produced — with the potential to increase up to 50% by the end of 2023. The certified plastic waste diversion is achieved by allocating recycled waste plastic to Eastman Renew materials using an ISCC certified mass balance process.
Nelipak’s use of Eastar Renew 6763 in sterile barrier packaging products, is enabled by Nelipak’s ISCC PLUS certified facilities as well as ISCC PLUS certification at other supply chain partners. ISCC PLUS is a globally recognised third-party certification system for tracking sustainable feedstocks through the supply chain.
“The use of Eastar Renew 6763 in medical device packaging is an important step towards circularity for packaging in the healthcare industry,” said Pat Chambliss, CEO of Nelipak. “We are excited to work with customers on projects where this new medical-grade material can play an important role in achieving their sustainability goals.”
“Developing sustainable solutions and increasing circularity are priorities for many of our customers,” said Nic Hunt, Nelipak’s global head of sustainability. “An exciting benefit of working with Eastar Renew 6763 is the ease of adoption as a result of its performance characteristics. This can help customers accelera te projects which contribute to achieving sustainability objectives.”